Instil Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.98 | -$2.98 | -$2.98 |
| Q2 2024 | 1 | -$2.11 | -$2.11 | -$2.11 |
| Q3 2024 | 1 | -$3.86 | -$1.09 | -$2.48 |
| Q1 2025 | 1 | -$3.37 | -$3.37 | -$3.37 |
| Q2 2025 | 1 | -$3.80 | -$3.80 | -$3.80 |
| Q3 2025 | 1 | -$3.94 | -$3.94 | -$3.94 |
| Q4 2025 | 1 | -$4.11 | -$4.11 | -$4.11 |
Instil Bio, Inc. Earnings Date And Information
Instil Bio, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-3.54 earnings per share for the quarter, missing analysts' consensus estimates of $-2.08 by $1.46. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Instil Bio, Inc. has generated $-24 earnings per share over the last year ($-24 diluted earnings per share) and currently has a price-to-earnings ratio of -2.14. Instil Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Instil Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$2.08 | -$3.54 | -1.46 | $1.90 M | $0 |
| 08/13/2024 | Q2 2024 | -$3.04 | -$2.29 | 0.75 | $0 | $0 |
| 05/10/2024 | Q1 2024 | -$2.16 | -$3.74 | -1.58 | $0 | |
| 03/21/2024 | Q4 2023 | -$2.84 | -$1.99 | 0.85 | $7.67 M | |
| 11/13/2023 | Q3 2023 | -$2.80 | -$10.37 | -7.57 | $0 | |
| 08/14/2023 | Q2 2023 | -$4.00 | -$2.87 | 1.13 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.15 | -$8.66 | -8.51 | $0 | |
| 03/31/2023 | Q4 2022 | -$9.00 | -$8.29 | 0.71 | $0 | |
| 11/14/2022 | Q3 2022 | -$8.80 | -$0.43 | 8.37 | $0 | |
| 08/12/2022 | Q2 2022 | -$8.00 | -$0.46 | 7.54 | $0 | |
| 05/16/2022 | Q1 2022 | -$7.60 | -$0.42 | 7.18 | $0 | |
| 03/07/2022 | Q4 2021 | -$7.40 | -$0.43 | 6.97 | $0 | |
| 11/15/2021 | Q3 2021 | -$6.60 | -$0.33 | 6.27 | $0 | |
| 08/12/2021 | Q2 2021 | -$4.20 | -$0.27 | 3.93 | $0 | |
| 05/13/2021 | Q1 2021 | -$0.52 | -$0.66 | -0.14 | $0 | |
| 12/31/2020 | Q4 2020 | -$0.49 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.12 | $52,000 | |||
| 06/29/2020 | Q2 2020 | -$0.15 | $42,000 | |||
| 03/30/2020 | Q1 2020 | -$0.07 | $44,000 |
Instil Bio, Inc. Earnings: Frequently Asked Questions
-
When is Instil Bio, Inc.'s earnings date?
Instil Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based off last year's report dates.
-
How can I listen to Instil Bio, Inc.'s earnings conference call?
The conference call for Instil Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Instil Bio, Inc.'s conference call transcript?
The conference call transcript for Instil Bio, Inc.'s latest earnings report can be read online.
-
How much profit does Instil Bio, Inc. generate each year?
Instil Bio, Inc. (:TIL) has a recorded net income of $0. Instil Bio, Inc. has generated $-24 earnings per share over the last four quarters.
-
What is Instil Bio, Inc.'s price-to-earnings ratio?
Instil Bio, Inc. (:TIL) has a price-to-earnings ratio of -2.14 and price/earnings-to-growth ratio is -0.06.
